Health Japan’s Kowa says ivermectin effective against Omicron in phase III trial Mexus | February 1, 2022 TOKYO (Reuters) – Japanese trading and pharmaceutical company Kowa Co Ltd said on Monday anti-parasite human drug ivermectin has been found effective for treating the Omicron variant of Read More